Recognition of allergic conjunctivitis in patients with allergic rhinitis

World Allergy Organization Journal

Volumn 6, Issue 1, 2013, Pages

  Williams, Daniel C ^a   Edney, Gabrielle ^a   Maiden, Bianca ^a   Smith, Peter K ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OLOPATADINE;

ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ARTICLE; BLINKING; CONTROLLED STUDY; DERMATITIS; EPIPHORA; EYELID DISEASE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SCREENING; SYMPTOMATOLOGY; TOTAL OCULAR SYMPTOM SCORE;

EID: 84887572824     PISSN: 19394551     EISSN: None     Source Type: Journal    
DOI: 10.1186/1939-4551-6-4     Document Type: Article

References (22)

1. DeWester J, Philpot EE, Westlund RE, et al: The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc 2003, 24:331-337. Abstract. (Pubitemid 37414434)
2. Meltzer EO, Bachert C, Bloom M, et al: Efficacy of intranasal mometasone furoate for the treatment of ocular symptoms in patients with seasonal allergic rhinitis. Allergy Clin Immunol Int 2005, 17:Abstract 709.
3. Neffen H, Mello JF, Sole D, Naspitz CK, Dodero AE, Garza HL, et al: Nasal allergies in the Latin American population: results from the allergies in Latin America survey. Allergy Asthma Proc 2010, 31(Supp1):S9-S27.
4. Austin JB, Kaur B, Anderson HR, et al: Hay fever, eczema, and wheeze: a nationwide UK study (ISAAC, international study of asthma and allergies in childhood). Arch Dis Child 1999, 81:225-230. Abstract. (Pubitemid 29398383)
5. Nathan RA, Meltzer EO, Selner JC, et al: Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol 1997, 99:S808-S814. (Pubitemid 27282204)
6. Bielory L: Allergic conjunctivitis and the impact of allergic rhinitis. Curr Allergy Asthma Rep 2010, 10:122-134.
7. Wüthrich B, Brignoli R, Canevascini M, Gerber M: Epidemiological survey in hay fever patients: symptom prevalence and severity and influence on patient management. Schweiz Med Wochenschr 1998, 128:139-143. (Pubitemid 28052760)
8. Bauchau V, Durham SR: Prevalence and rate of diagnosis of allergic rhinitis in Europe. ER Journal 2004, 24(5):758-764. (Pubitemid 39504428)
9. Yanni JM, Stephens DJ, Miller ST, et al: The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective ati-allergic /antihistaminic agent. J Ocul Pharmacol Ther 1996, 12(4):389-400. (Pubitemid 26405743)
10. Kockaya G, Wertheimer A: Cost effectiveness analysis of five different treatment alternatives in seasonal allergic conjunctivitis. JAPS 2011, 01(05):72-75.
11. Yanni JM, Weier LK, Sharif NA, Xu SX, Gamache DA, Spellman JM: Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs. Arch Ophthalmol 1999, 117(5):643-647. (Pubitemid 29218431)
12. Sharif NA, Xu SX, Yanni JM: Olopatadine (AL-4943A): ligand binding and functional tudies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allgeric conjunctivitis. J Ocul Pharmacol Ther 1996, 12(4):401-407. (Pubitemid 26405744)
13. Nathan RA, Meltzer EO, Derebery J, et al: The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in America survey. Allergy Asthma Proc 2008, 29:600-608.
14. Bonini S, Bonini S: Studies of allergic conjunctivitis. Chibret Int J 1987, 5:12-22.
15. Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108(5):S147-S334.
16. Strachan D, Sibbald B, Weiland S, Ait-Khaled N, Anabwani G, Anderson HR, et al: Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the international study of asthma and allergies in childhood (ISAAC). Pediatr Allergy Immunol 1997, 8(4):161-168.
17. Braun-Fahrlander C, Wuthrich B, Gassner M, Grize L, Sennhauser FH, Varonier HS, et al: Validation of a rhinitis symptom questionnaire (ISAAC core questions) in a population of Swiss school children visiting the school health services. Pediatr Allergy Immunol 1997, 8(2):75-82. (Pubitemid 27483081)
18. Neilson R, Bielory L: Epidemiology of allergic conjunctivitis. Curr Opin Allergy Clin Immunol 2011, 11:471-476.
19. Alrasyid H, McManus A, Mallon D, Nicholson C: Elevated body mass index is associated with severity of allergic rhinitis: results from a cross sectional study. Australas Med J 2008, 2:XXXXX.
20. Ono SJ, Abelson MB: Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 2005, 115:118-122. (Pubitemid 40075430)
21. Blaiss MS: Allergic rhinoconjunctivitis: burden of disease. Allergy Asthma Proc 2007, 28:393-397.
22. Pitt AD, Smith AF, Lindsell L, et al: Economic and quality-of life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol 2004, 11:17-33. (Pubitemid 38367076)